1. Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study). Issue 9 (30th October 2018) Authors: Romero-Laorden, Nuria; Lozano, Rebeca; Jayaram, Anuradha; López-Campos, Fernando; Saez, Maria; Montesa, Alvaro; Gutierrez-Pecharoman, Ana; Villatoro, Rosa; Herrera, Bernardo; Correa, Raquel; Rosero, Adriana; Pacheco, María; Garcés, Teresa; Cendón, Ylenia; Nombela, Ma; Poll, Floortje; Grau, Gala; ... Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗